[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20044107L - Medicines containing betamimetics and a new anticholinergic drug - Google Patents

Medicines containing betamimetics and a new anticholinergic drug

Info

Publication number
NO20044107L
NO20044107L NO20044107A NO20044107A NO20044107L NO 20044107 L NO20044107 L NO 20044107L NO 20044107 A NO20044107 A NO 20044107A NO 20044107 A NO20044107 A NO 20044107A NO 20044107 L NO20044107 L NO 20044107L
Authority
NO
Norway
Prior art keywords
medicines containing
anticholinergic drug
betamimetics
new anticholinergic
containing betamimetics
Prior art date
Application number
NO20044107A
Other languages
Norwegian (no)
Inventor
Georg Speck
Richard Reichl
Christopher John Montagu Meade
Helmut Meissner
Gerd Morschhauser
Michael P Pieper
Gerald Pohl
Rolf Banholzer
Michel Pairet
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044107L publication Critical patent/NO20044107L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
NO20044107A 2002-04-12 2004-09-27 Medicines containing betamimetics and a new anticholinergic drug NO20044107L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (en) 2002-04-12 2002-12-03 Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
PCT/EP2003/003669 WO2003087097A1 (en) 2002-04-12 2003-04-09 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Publications (1)

Publication Number Publication Date
NO20044107L true NO20044107L (en) 2004-11-04

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044107A NO20044107L (en) 2002-04-12 2004-09-27 Medicines containing betamimetics and a new anticholinergic drug

Country Status (19)

Country Link
EP (1) EP1497289B1 (en)
JP (1) JP2005529111A (en)
CN (1) CN1646527A (en)
AT (1) ATE302774T1 (en)
AU (1) AU2003232201B2 (en)
BR (1) BR0309185A (en)
CA (1) CA2481468C (en)
DK (1) DK1497289T3 (en)
ES (1) ES2248767T3 (en)
HR (1) HRP20040944B1 (en)
IL (1) IL164291A (en)
MX (1) MXPA04009916A (en)
NO (1) NO20044107L (en)
NZ (1) NZ536337A (en)
PL (1) PL213489B1 (en)
PT (1) PT1497289E (en)
RS (1) RS50735B (en)
UY (1) UY27757A1 (en)
WO (1) WO2003087097A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (en) 2003-02-14 2005-01-01 Theravance Inc BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
EP1577306A1 (en) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
CN101119706B (en) 2005-02-25 2013-04-17 奇斯药制品公司 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a chelating agent
JP2009504624A (en) 2005-08-08 2009-02-05 アージェンタ ディスカバリー リミテッド Bicyclo [2.2.1] hept-7-ylamine derivatives and uses thereof
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (en) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Component surface coating method
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
PL2835146T3 (en) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizer
KR102443737B1 (en) 2014-05-07 2022-09-19 베링거 인겔하임 인터내셔날 게엠베하 Container, nebulizer and use
JP6559157B2 (en) 2014-05-07 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
PL3139981T3 (en) 2014-05-07 2021-06-14 Boehringer Ingelheim International Gmbh Nebulizer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE10050995A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
CN1646527A (en) 2005-07-27
IL164291A0 (en) 2005-12-18
AU2003232201B2 (en) 2009-06-11
EP1497289A1 (en) 2005-01-19
IL164291A (en) 2012-04-30
WO2003087097A1 (en) 2003-10-23
MXPA04009916A (en) 2005-05-03
HRP20040944B1 (en) 2012-12-31
EP1497289B1 (en) 2005-08-24
AU2003232201A1 (en) 2003-10-27
ES2248767T3 (en) 2006-03-16
BR0309185A (en) 2005-02-15
CA2481468C (en) 2011-02-01
PL213489B1 (en) 2013-03-29
UY27757A1 (en) 2003-11-28
NZ536337A (en) 2007-05-31
PL372450A1 (en) 2005-07-25
ATE302774T1 (en) 2005-09-15
DK1497289T3 (en) 2005-10-24
HRP20040944A2 (en) 2005-04-30
PT1497289E (en) 2005-11-30
RS89804A (en) 2006-10-27
JP2005529111A (en) 2005-09-29
CA2481468A1 (en) 2003-10-23
RS50735B (en) 2010-08-31

Similar Documents

Publication Publication Date Title
NO20044107L (en) Medicines containing betamimetics and a new anticholinergic drug
HUP0301447A2 (en) Combined pharmaceutical compositions containing tiotropium and salmeterol salts
DE60315492D1 (en) MEDICALLY USEFUL ARYLETHANOLAMINE COMPOUNDS
RS20050361A (en) Novel medicament for the treatment of chronic obstructive pulmonary diseases
CY1106430T1 (en) MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG
ATE365720T1 (en) AGONISTS OF BETA-ADRENORECEPTORS
YU71901A (en) NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS
SE0104341D0 (en) New use
EA200600223A1 (en) SUBSTITUTED 2-AMINOTHETRALINES FOR THE TREATMENT OF DEPRESSION
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
EA200600854A1 (en) NEW TIOTROPY SALTS, METHOD OF THEIR PRODUCTION, AND ALSO CONTAINING THEIR MEDICINAL COMPOSITIONS
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SE0101978D0 (en) New compounds
BR0307703A (en) Drug compositions based on anticholinergic agents and egfr kinase inhibitors
DE602004019096D1 (en) MEDICAMENTS FOR INHALATION WITH BETAMIMETICS AND ANTICHOLINERGICUM
UY26990A1 (en) NEW DRUG COMPOSITIONS
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
DE502007006951D1 (en) MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
DK1581224T3 (en) Tiotropium-containing drug composition for inhalation
UY27686A1 (en) NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
ECSP003424A (en) NEW COMPOSITIONS OF MEDICINES BASED ON ANTI-POLINERGICALLY ACTIVE AND ß-MIMETIC COMPOUNDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application